Abstract:Sepsis-associated cerebral dysfunction is complex pathophysiology, generated from primary infections that are developed elsewhere in the body. The neonates, elderly population and chronically ill and long-term hospitalized patients are predominantly vulnerable to sepsis and related cerebral damage. Generally, electrophysiological recordings, severity and sedation scales, computerized imaging and spectroscopy techniques are used for its detection and diagnosis. About the underlying mechanisms, enhanced blood-brain barrier permeability and metalloprotease activity, tight junction protein loss and endothelial cell degeneration promote the influx of inflammatory and toxic mediators into the brain, triggering cerebrovascular damage. An altered neutrophil count and phenotype further dysregulate the normal neuroimmune responses and neuroendocrine stability via modulated activation of protein kinase C-delta, nuclear factor kappa-B and sphingolipid signaling. Glial activation, together with pro-inflammatory cytokines and chemokines and the Toll-like receptor, destabilize the immune system. Moreover, superoxides and hydroperoxides generate oxidative stress and perturb mitochondrial dynamics and ATP synthesis, propagating neuronal injury cycle. Activated mitochondrial apoptotic pathway, characterized by increased caspase-3 and caspase-9 cleavage and Bax/Bcl2 ratio in the hippocampal and cortical neurons, stimulate neurocognitive impairments. Additionally, altered LC3-II/I and P62/SQSTM1, p-mTOR, p-AMPK1 and p-ULK1 levels and dysregulated autophagosome-lysosome fusion decrease neuronal and glial energy homeostasis. The therapies and procedures for attenuating sepsis-induced brain damage include early resuscitation, cerebral blood flow autoregulation, implantable electric vagus nerve stimulation, antioxidants, statins, glucocorticoids, neuroimmune axis modulators and PKCδ inhibitors. The current review enumerates the pathophysiology of sepsis-induced brain damage, its diagnosis, the role of critical inducers and mediators and, ultimately, therapeutic measures attenuating cerebrovascular degeneration.

Research progress on the role of mitochondrial quality control in sepsis associated encephalopathy

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure

Basic research and clinical progress of sepsis-associated encephalopathy

Review on the Role of Mitochondrial Dysfunction in Septic Encephalopathy

Research progress in the pathogenesis of sepsis-associated encephalopathy

[Research progress of mitochondrial dysfunction in the pathogenesis of septic acute kidney injury].

The Advance of Pathogenesis of Sepsis-Associated Encephalopathy

[Research of Progress of Mitochondria in the Pathogenesis of Sepsis].

Progress in Research of Pathogenesis of Septic Encephalopathy

[Research advances in prevention and treatment of cerebral ischemia-reperfusion injury by targeting mitochondrial quality control]

Mitochondrial Fusion and Fission in Neuronal Death Induced by Cerebral Ischemia-Reperfusion and Its Clinical Application: A Mini-Review

The emerging role of mtDNA release in sepsis: Current evidence and potential therapeutic targets

Potential Therapy Strategy: Targeting Mitochondrial Dysfunction in Sepsis

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

[Research progress on the role of microglia in sepsis-associated encephalopathy]

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial quality control in the brain: The physiological and pathological roles

Sepsis-associated encephalopathy: Autophagy and miRNAs regulate microglial activation

Sepsis and Cerebral Dysfunction: BBB Damage, Neuroinflammation, Oxidative Stress, Apoptosis and Autophagy as Key Mediators and the Potential Therapeutic Approaches

Progress in the Mechanism of Mitochondrial Dysfunction in Septic Cardiomyopathy

Mitochondrial Quality Control: A Pathophysiological Mechanism and Therapeutic Target for Stroke